I am the President of Golden Eagle Capital Advisors, Inc., an international investment bank with Italian roots devoted, since more than a decade, to socially help organizations in their development through application of ESG principles on our direct investment as strategic partner.

We have committed $ 3 mln towards investment in biotech and pharma small and micro companies that are on clinical trials for the research of the cure and the vaccine of COVID-19.

Currently there are more than 40 companies recognised by the World Health Organization for the vaccine preclinical status, and more than 200 that are in the course of implementing COVID-19 pneumonia treatments under clinical trials. Most of them (above 80%) are small and micro enterprises.

Thanks to our 20 years of exposure on the Life Science industry, we are already able to identify the most reputable companies currently active in developing an high level of medical research.

Please help us further increase the amount that will be invested in 10-15 small and micro international biotech and pharma companies (including spin off), and contribute on common human progresses for the benefit and protection of our lives.

Targets are waiting, we are looking forward in having you on board as an investor now!